Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001
- PMID: 18159416
- PMCID: PMC2094894
- DOI: 10.1155/2002/891673
Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001
Abstract
The relative frequency of serogroups of Neisseria meningitidis associated with meningococcal disease in Canada during the period January 1, 1999 to June 30, 2001 was examined. Of the 552 strains of N meningitidis collected from clinical specimens of normally sterile sites, 191 (34.6%), 276 (50.0%), 61 (11.1%) and 23 (4.2%) were identified by serological and molecular methods as serogroups B, C, Y and W135, respectively. About half (50.8%) of the serogroup Y isolates were isolated in the province of Ontario. The two most common serotypes found were 2c and 14. Most of the serogroup Y strains isolated from patients in Ontario were serotype 2c, while serotype 14 was the most common serotype associated with disease in the province of Quebec. The two most common serosubtypes found among the serogroup Y meningococci were P1.5 and P1.2,5. Laboratory findings, based on antigenic analysis, did not suggest that these serogroup Y strains arise by capsule switching from serogroups B and C strains. This study documented a higher incidence of finding serogroup Y meningococci in clinical specimens from patients in Ontario compared to the rest of Canada, and parallels the increase in serogroup Y meningococcal disease reported in some parts of the United States.
Keywords: Meningococcal disease; Neisseria meningitidis; Serogroups.
Figures
Similar articles
-
Potential capsule switching from serogroup Y to B: The characterization of three such Neisseria meningitidis isolates causing invasive meningococcal disease in Canada.Can J Infect Dis Med Microbiol. 2005 May;16(3):171-4. doi: 10.1155/2005/216369. Can J Infect Dis Med Microbiol. 2005. PMID: 18159539 Free PMC article.
-
Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.Can J Microbiol. 2003 Oct;49(10):633-8. doi: 10.1139/w03-074. Can J Microbiol. 2003. PMID: 14663497
-
Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan.BMC Infect Dis. 2006 Feb 15;6:25. doi: 10.1186/1471-2334-6-25. BMC Infect Dis. 2006. PMID: 16478548 Free PMC article.
-
Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness.Expert Rev Vaccines. 2023 Jan-Dec;22(1):738-748. doi: 10.1080/14760584.2023.2244596. Expert Rev Vaccines. 2023. PMID: 37622470 Review.
-
Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).Postgrad Med. 2016 Aug;128(6):548-56. doi: 10.1080/00325481.2016.1203238. Epub 2016 Jul 7. Postgrad Med. 2016. PMID: 27467048 Review.
Cited by
-
Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006.Antimicrob Agents Chemother. 2010 Mar;54(3):1016-21. doi: 10.1128/AAC.01077-09. Epub 2010 Jan 19. Antimicrob Agents Chemother. 2010. PMID: 20086160 Free PMC article.
-
Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada.J Clin Microbiol. 2007 Jun;45(6):1753-8. doi: 10.1128/JCM.02134-06. Epub 2007 Apr 18. J Clin Microbiol. 2007. PMID: 17442798 Free PMC article.
-
Potential capsule switching from serogroup Y to B: The characterization of three such Neisseria meningitidis isolates causing invasive meningococcal disease in Canada.Can J Infect Dis Med Microbiol. 2005 May;16(3):171-4. doi: 10.1155/2005/216369. Can J Infect Dis Med Microbiol. 2005. PMID: 18159539 Free PMC article.
-
Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C:2a:P1.7,1) causing invasive meningococcal disease in Quebec, Canada.J Clin Microbiol. 2004 Apr;42(4):1460-5. doi: 10.1128/JCM.42.4.1460-1465.2004. J Clin Microbiol. 2004. PMID: 15070989 Free PMC article.
-
Outbreak of serogroup C meningococcal disease caused by a variant of Neisseria meningitidis serotype 2a ET-15 in a community of men who have sex with men.J Clin Microbiol. 2003 Sep;41(9):4411-4. doi: 10.1128/JCM.41.9.4411-4414.2003. J Clin Microbiol. 2003. PMID: 12958279 Free PMC article.
References
-
- Achtman M. Global epidemiology of meningococcal disease. In: Cartwright K, ed. Meningococcal Disease. Chichester: John Wiley & Sons, 1995:159-75.
-
- Squires SG, Pelletier L, Mungai M, et al. Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998. Can Commun Dis Rep 2000;26:177-82. - PubMed
-
- Centers for Disease Control and Prevention. Serogroup Y meningococcal disease: Illinois, Connecticut, and selected areas, United States, 1989-1996. MMWR Morb Mortal Wkly Rep 1996;45:1010-3. - PubMed
-
- Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 1999;180:1894-901. - PubMed
LinkOut - more resources
Full Text Sources